Clinical Trial Update: Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

A safety and efficacy study of IGF-1 in Duchenne Muscular Dystrophy completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• IGF-1 (insulin-like growth factor 1)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-20